_id
6911c1d2ccc777a4e85d63df
Ticker
GWLL
Name
Goldenwell Biotech Inc
Exchange
PINK
Address
581 Boston Mills Road, Hudson, OH, United States, 44236
Country
USA
Sector
Consumer Defensive
Industry
Packaged Foods
Currency
USD
Website
https://www.goldenwellbiotech.com
Description
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Last Close
2.9
Volume
-
Current Price
2.8
Change
-1.6949152542372972
Last Updated
2026-01-04T14:11:59.723Z
Image
-
Ipo Date
-
Market Cap
287100000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
25000
Cost Of Revenue
0
Gross Profit
25000
Operating Expenses
30885
Operating Income
-5885
Interest Expense
-2100
Pretax Income
-7985
Net Income
-7985
Eps
-0.00008280331864086871
Dividends Per Share
-
Shares Outstanding
99000000
Income Tax Expense
-
EBITDA
-5885
Operating Margin
-23.54
Total Other Income Expense Net
-2100
Cash
45622
Short Term Investments
-
Receivables
0
Inventories
174788
Total Current Assets
220410
Property Plant Equipment
0
Total Assets
220410
Payables
0
Short Term Debt
-
Long Term Debt
95588
Total Liabilities
315233
Equity
-94823
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-25000
Cash From Operations
-30885
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-30885
Cf_currency_symbol
USD
PE
0
PB
-2847.551041414003
ROE
8.420952722440758
ROA
-3.6227938841250396
FCF
-30885
Fcf Percent
-1.2354
Piotroski FScore
0
Health Score
21
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
0.5
Value Investing Score
1
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
25000
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
25000
Quarters > 0 > income Statement > operating Expenses
30885
Quarters > 0 > income Statement > operating Income
-5885
Quarters > 0 > income Statement > interest Expense
-2100
Quarters > 0 > income Statement > pretax Income
-7985
Quarters > 0 > income Statement > net Income
-7985
Quarters > 0 > income Statement > eps
-0.00008280331864086871
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
96433333
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-5885
Quarters > 0 > income Statement > operating Margin
-23.54
Quarters > 0 > income Statement > total Other Income Expense Net
-2100
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
45622
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
174788
Quarters > 0 > balance Sheet > total Current Assets
220410
Quarters > 0 > balance Sheet > property Plant Equipment
0
Quarters > 0 > balance Sheet > total Assets
220410
Quarters > 0 > balance Sheet > payables
0
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
95588
Quarters > 0 > balance Sheet > total Liabilities
315233
Quarters > 0 > balance Sheet > equity
-94823
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-7985
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-25000
Quarters > 0 > cash Flow > cash From Operations
-30885
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-30885
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.00008280331864086871
Quarters > 0 > ratios > PB
-2847.551041414003
Quarters > 0 > ratios > ROE
8.420952722440758
Quarters > 0 > ratios > ROA
-3.6227938841250396
Quarters > 0 > ratios > FCF
-30885
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.2354
Quarters > 0 > health Score
21
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
37500
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
37500
Quarters > 1 > income Statement > operating Expenses
40620
Quarters > 1 > income Statement > operating Income
-3120
Quarters > 1 > income Statement > interest Expense
2100
Quarters > 1 > income Statement > pretax Income
-5220
Quarters > 1 > income Statement > net Income
-5220
Quarters > 1 > income Statement > eps
-0.000054130660401419495
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
96433333
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3120
Quarters > 1 > income Statement > operating Margin
-8.32
Quarters > 1 > income Statement > total Other Income Expense Net
-2100
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
76507
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
0
Quarters > 1 > balance Sheet > inventories
174788
Quarters > 1 > balance Sheet > total Current Assets
251295
Quarters > 1 > balance Sheet > property Plant Equipment
0
Quarters > 1 > balance Sheet > total Assets
251295
Quarters > 1 > balance Sheet > payables
0
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
95588
Quarters > 1 > balance Sheet > total Liabilities
338133
Quarters > 1 > balance Sheet > equity
-86838
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5219
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
62500
Quarters > 1 > cash Flow > cash From Operations
59381
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
59380
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.000054130660401419495
Quarters > 1 > ratios > PB
-3109.3914231096983
Quarters > 1 > ratios > ROE
6.011193256408485
Quarters > 1 > ratios > ROA
-2.0772398973318213
Quarters > 1 > ratios > FCF
59381
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
1.5834933333333334
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
-158
Quarters > 2 > income Statement > cost Of Revenue
-73
Quarters > 2 > income Statement > gross Profit
-85
Quarters > 2 > income Statement > operating Expenses
32277
Quarters > 2 > income Statement > operating Income
-32277
Quarters > 2 > income Statement > interest Expense
2100
Quarters > 2 > income Statement > pretax Income
-34377
Quarters > 2 > income Statement > net Income
-34377
Quarters > 2 > income Statement > eps
-0.0003472424242424242
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
99000000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-32277
Quarters > 2 > income Statement > operating Margin
20428.481012658227
Quarters > 2 > income Statement > total Other Income Expense Net
-2100
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
17127
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
174788
Quarters > 2 > balance Sheet > total Current Assets
191915
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
191915
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
95588
Quarters > 2 > balance Sheet > total Liabilities
273533
Quarters > 2 > balance Sheet > equity
-81618
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-34377
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
85
Quarters > 2 > cash Flow > cash From Operations
-32277
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
63700
Quarters > 2 > cash Flow > net Change In Cash
-32277
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.0003472424242424242
Quarters > 2 > ratios > PB
-3396.3096375799455
Quarters > 2 > ratios > ROE
42.11938542968463
Quarters > 2 > ratios > ROA
-17.91261756506787
Quarters > 2 > ratios > FCF
-32277
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
204.28481012658227
Quarters > 2 > health Score
49
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-158
Quarters > 3 > income Statement > cost Of Revenue
-73
Quarters > 3 > income Statement > gross Profit
-85
Quarters > 3 > income Statement > operating Expenses
18978
Quarters > 3 > income Statement > operating Income
-19136
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-27536
Quarters > 3 > income Statement > net Income
-27536
Quarters > 3 > income Statement > eps
-0.0002781414141414141
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
99000000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
12111.392405063292
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
49404
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
174788
Quarters > 3 > balance Sheet > total Current Assets
224192
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
224192
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
95588
Quarters > 3 > balance Sheet > total Liabilities
271433
Quarters > 3 > balance Sheet > equity
-47241
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-27536
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
85
Quarters > 3 > cash Flow > cash From Operations
-19051
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
63700
Quarters > 3 > cash Flow > net Change In Cash
44649
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.0002781414141414141
Quarters > 3 > ratios > PB
-5867.784339874262
Quarters > 3 > ratios > ROE
58.288351220338264
Quarters > 3 > ratios > ROA
-12.282329431915501
Quarters > 3 > ratios > FCF
-19051
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
120.57594936708861
Quarters > 3 > health Score
49
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
139
Annuals > 0 > income Statement > cost Of Revenue
75
Annuals > 0 > income Statement > gross Profit
64
Annuals > 0 > income Statement > operating Expenses
123162
Annuals > 0 > income Statement > operating Income
-123098
Annuals > 0 > income Statement > interest Expense
8400
Annuals > 0 > income Statement > pretax Income
-131498
Annuals > 0 > income Statement > net Income
-131498
Annuals > 0 > income Statement > eps
-0.0013282626262626264
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
99000000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-123098
Annuals > 0 > income Statement > operating Margin
-88559.71223021582
Annuals > 0 > income Statement > total Other Income Expense Net
-8400
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
49404
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
174788
Annuals > 0 > balance Sheet > total Current Assets
224192
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
224192
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
95588
Annuals > 0 > balance Sheet > total Liabilities
271433
Annuals > 0 > balance Sheet > equity
-47241
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-131498
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
21
Annuals > 0 > cash Flow > cash From Operations
-123077
Annuals > 0 > cash Flow > capital Expenditures
3
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
119250
Annuals > 0 > cash Flow > net Change In Cash
-3827
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.0013282626262626264
Annuals > 0 > ratios > PB
-6077.348066298343
Annuals > 0 > ratios > ROE
278.35566562943205
Annuals > 0 > ratios > ROA
-58.65418926634314
Annuals > 0 > ratios > FCF
-123080
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-885.4676258992806
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2340
Annuals > 1 > income Statement > cost Of Revenue
1232
Annuals > 1 > income Statement > gross Profit
1108
Annuals > 1 > income Statement > operating Expenses
118003
Annuals > 1 > income Statement > operating Income
-116895
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-116895
Annuals > 1 > income Statement > net Income
-116895
Annuals > 1 > income Statement > eps
-0.00121218458766742
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
96433333
Annuals > 1 > income Statement > income Tax Expense
-116895
Annuals > 1 > income Statement > EBITDA
-116895
Annuals > 1 > income Statement > operating Margin
-4995.51282051282
Annuals > 1 > income Statement > total Other Income Expense Net
-116895
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
53231
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
174825
Annuals > 1 > balance Sheet > total Current Assets
228056
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
228057
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
95588
Annuals > 1 > balance Sheet > total Liabilities
143334
Annuals > 1 > balance Sheet > equity
84723
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-116895
Annuals > 1 > cash Flow > depreciation
116895
Annuals > 1 > cash Flow > change In Working Capital
2206
Annuals > 1 > cash Flow > cash From Operations
-114689
Annuals > 1 > cash Flow > capital Expenditures
1
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
121924
Annuals > 1 > cash Flow > net Change In Cash
7235
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.00121218458766742
Annuals > 1 > ratios > PB
3300.835259610731
Annuals > 1 > ratios > ROE
-137.97315959066606
Annuals > 1 > ratios > ROA
-51.2569226114524
Annuals > 1 > ratios > FCF
-114690
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-49.01282051282051
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
47800
Annuals > 2 > income Statement > cost Of Revenue
22614
Annuals > 2 > income Statement > gross Profit
25186
Annuals > 2 > income Statement > operating Expenses
1032905
Annuals > 2 > income Statement > operating Income
-985105
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-985097
Annuals > 2 > income Statement > net Income
-985097
Annuals > 2 > income Statement > eps
-0.010215316315987958
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
96433333
Annuals > 2 > income Statement > income Tax Expense
-985105
Annuals > 2 > income Statement > EBITDA
-985105
Annuals > 2 > income Statement > operating Margin
-2060.889121338912
Annuals > 2 > income Statement > total Other Income Expense Net
8
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
45996
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
176058
Annuals > 2 > balance Sheet > total Current Assets
222054
Annuals > 2 > balance Sheet > property Plant Equipment
26346
Annuals > 2 > balance Sheet > total Assets
248400
Annuals > 2 > balance Sheet > payables
-26782
Annuals > 2 > balance Sheet > short Term Debt
25372
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
46782
Annuals > 2 > balance Sheet > equity
201618
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-985097
Annuals > 2 > cash Flow > depreciation
985105
Annuals > 2 > cash Flow > change In Working Capital
-87466
Annuals > 2 > cash Flow > cash From Operations
-1072560
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
905000
Annuals > 2 > cash Flow > net Change In Cash
-167560
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.010215316315987958
Annuals > 2 > ratios > PB
1387.0619969447173
Annuals > 2 > ratios > ROE
-488.59576029917963
Annuals > 2 > ratios > ROA
-396.5768921095008
Annuals > 2 > ratios > FCF
-1072560
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-22.438493723849373
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
15967
Annuals > 3 > income Statement > cost Of Revenue
7579
Annuals > 3 > income Statement > gross Profit
8388
Annuals > 3 > income Statement > operating Expenses
134234
Annuals > 3 > income Statement > operating Income
-118267
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-116981
Annuals > 3 > income Statement > net Income
-116981
Annuals > 3 > income Statement > eps
-0.001280969707460688
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
91322222
Annuals > 3 > income Statement > income Tax Expense
-118267
Annuals > 3 > income Statement > EBITDA
-118267
Annuals > 3 > income Statement > operating Margin
-740.6964364000752
Annuals > 3 > income Statement > total Other Income Expense Net
1286
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
213556
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
198671
Annuals > 3 > balance Sheet > total Current Assets
412227
Annuals > 3 > balance Sheet > property Plant Equipment
48752
Annuals > 3 > balance Sheet > total Assets
460979
Annuals > 3 > balance Sheet > payables
111488
Annuals > 3 > balance Sheet > short Term Debt
47779
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
159265
Annuals > 3 > balance Sheet > equity
301714
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-116981
Annuals > 3 > cash Flow > depreciation
118267
Annuals > 3 > cash Flow > change In Working Capital
-88157
Annuals > 3 > cash Flow > cash From Operations
-205138
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
170125
Annuals > 3 > cash Flow > net Change In Cash
-35013
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.001280969707460688
Annuals > 3 > ratios > PB
877.7665066917676
Annuals > 3 > ratios > ROE
-38.77214845847392
Annuals > 3 > ratios > ROA
-25.37664405536912
Annuals > 3 > ratios > FCF
-205138
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-12.847623222897225
Annuals > 3 > health Score
23
Valuation > metrics > PE
-0.00008280331864086871
Valuation > metrics > PB
-2847.551041414003
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
8.420952722440758
Profitability > metrics > ROA
-3.6227938841250396
Profitability > metrics > Net Margin
-0.3194
Profitability > final Score
17
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-2.802380952380952
Risk > final Score
19
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
12
Prev Profitabilities > 1
70
Prev Profitabilities > 2
70
Prev Risks > 0
24
Prev Risks > 1
-31
Prev Risks > 2
50
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T21:56:48.586Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0001
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0001
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0003
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-09-30
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0002
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-06-30
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0005
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-03-31
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0003
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2023-12-31
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0002
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-09-30
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0004
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-06-30
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0003
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-03-31
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0003
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-12-31
Earnings History > 10 > report Date
2022-12-31
Earnings History > 10 > date
2022-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0095
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-09-30
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0001
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHigher cash checks ahead as Genesis Energy lifts quarterly payouts 9.1% Stock Titan
Read more →GEL: Strong Performance In 2025 And Well-Positioned For 2026 (NYSE:GEL) Seeking Alpha
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Goldenwell Biotech Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0001
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.